PNC Financial Services Group
CDAK

PNC Financial Services Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

PNC Financial Services Group’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$2K – 4776
2021
Q4 		$2K Hold
200
– – ﹤0.01% 4218
2021
Q3 		$4K Hold
200
– – ﹤0.01% 4015
2021
Q2 		$4K Buy
+200
New +$3.84K ﹤0.01% 3953

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PNC Financial Services Group's CDAK Position: Q1 2022 in Review

PNC Financial Services Group sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2022, closing a stake of 200 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in CDAK in Q2 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 62 funds tracked by Wall St. Rank hold CDAK as of Q1 2022.

  • PNC Financial Services Group reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 200 Codiak BioSciences, Inc. Common Stock shares in Q1 2022, an estimated $2K.
  • PNC Financial Services Group first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • PNC Financial Services Group's Codiak BioSciences, Inc. Common Stock position peaked at $4K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2022.

Based on PNC Financial Services Group's 13F filing for Q1 2022, filed 12 May 2022.